(Press-News.org) Amidation reactions are the most common reactions in the chemical industry. They are indispensable for a wide range of industrial production processes, but their ecological footprint is highly problematic. They generate large amounts of toxic waste and are energy-intensive. A team led by Dr Tobias Schnitzer, research group leader at the Institute of Organic Chemistry at the University of Freiburg, is using Artificial Intelligence (AI) to develop innovative, boronic acid-catalysed amidation reactions that do not require toxic reagents, use sustainable solvents and consume little energy. The research project is being funded by the Vector Foundation with £1.5 million over six years. “Our goal is the AI-driven development of an amidation process in which water is the only by-product, which is cost-effective and can significantly improve resource efficiency in the chemical industry,” says Schnitzer.
The development of catalysts for amidation
Around 16% of all reactions in the chemical industry are amidations. They are important for the production of pharmaceuticals, agrochemicals and polymers and play a central role in fine chemicals such as dyes, fragrances and additives. Classic amidation processes use chlorination and coupling reagents that are toxic, explosive or corrosive and produce large quantities of hazardous by-products. They also use toxic and poorly degradable solvents.
The Freiburg research project is developing novel boronic acid catalysts for efficient and sustainable amidations. The starting point is an extensive and structurally diverse catalyst library, which is being studied in high throughput with regard to its catalytic activity. The experimentally determined reactivity of each individual catalyst then serves as the data basis for the development of an AI-based prediction model. This model makes it possible to predict the properties and activities of hundreds of thousands of additional catalysts without their actual synthesis or experimental testing. This saves time, energy and chemical resources already in the development process.
Economical green chemistry
The aim of the research is to identify highly active catalysts that enable the amidation of any starting materials at room temperature in sustainable, bio-based solvents for the first time. The goal is to achieve an energy- and cost-efficient process with minimal waste for one of the most important chemical reactions.
The funded research work thus also makes a quantifiable contribution to achieving the United Nations' global sustainability goals, says Schnitzer: “Our project shows that green chemistry is feasible and economically relevant. I also hope that our work will help to change the image of chemistry – away from a ‘dirty and smelly’ science to a clean and sustainable discipline that delivers innovation and is part of the solution to global challenges.”
The Vector Foundation
The Vector Foundation was established in 2011 as a corporate foundation. The Vector Foundation supports an average of 170 projects with approximately twelve million euros annually. Since 2011, it has allocated more than 100 million euros to its charitable work. The Vector Foundation is active in the fields of research, education and social engagement in Baden-Württemberg. Its funding focuses on scientific and technical research projects, STEM education (science, technology, engineering and mathematics) and combating homelessness and youth unemployment.
About Dr Tobias Schnitzer
Dr Tobias Schnitzer has been head of the Target-selective Catalysis research group at the Institute of Organic Chemistry at the University of Freiburg since 2023. Among other honours, he has received a Liebig Fellowship from the Chemical Industry Fund and the Eugen Graetz Prize from the University of Freiburg, and is a member of the Baden-Württemberg Foundation's Elite Programme for Postdoctoral Researchers.
Contact
Office of University and Science Communications
Unviersity of Freiburg
Tel.: 0761/203-4302
kommunikation@zv.uni-freiburg.de
END
Sustainable chemistry with the help of Artificial Intelligence
2025-10-29
ELSE PRESS RELEASES FROM THIS DATE:
Quantum jam sessions teach quantum and jamming
2025-10-29
A new interactive web application allows for a tangible understanding of abstract concepts of quantum game theory. The Kobe University development parallels the emergent dialogue found in jazz and improvisational music and aims for a scientific exploration of creativity.
For many of us, quantum mechanics, game theory and jazz are difficult concepts by themselves, and it is hard to imagine how they would combine. But Kobe University quantum engineer SOUMA Satofumi posits that not only can they fruitfully interact, but their combination also provides new avenues to understanding each of them. Through creating the world’s first browser-based interactive ...
Health care professionals sponsored for H-1B visas in the US
2025-10-29
About The Study: Over 11,000 physicians were sponsored for H-1B visas in fiscal year 2024, representing 1% of the U.S. physician workforce. H-1B–sponsored advanced practice providers (physician assistants, nurse practitioners, nurse anesthetists, and nurse midwives), dentists, and other health care workers (podiatrists, chiropractors, and optometrists) accounted for a smaller share. The percentage of H-1B–sponsored physicians was nearly 2 times higher in rural compared with urban counties and nearly 4 times higher in the highest- vs lowest-poverty counties.
Corresponding Author: To contact the corresponding author, Rishi K. Wadhera, ...
Study shows increase of H1-B visa fees will most impact rural and high-poverty counties
2025-10-29
Investigators at Mass General Brigham and the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center have found that international doctors sponsored by H1-B visas in 2024 comprised nearly 1% of the entire physician workforce in the United States, with substantial variation in different counties’ reliance on H-1B-sponsored physicians and other healthcare professionals. The research, published in JAMA, comes out just weeks after a presidential proclamation that substantially increased employers’ fees for H1-B visa applications.
“Our ...
How age affects vaccine responses and how to make them better
2025-10-29
SEATTLE, WASH. — October 29, 2025 — As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists are learning why vaccines can trigger a weaker response in older adults, around age 65, and what can be done to improve them. These insights open the door to designing more effective vaccines.
In the largest study of its kind, published in Nature, scientists discovered that our T cells—key players in coordinating immune responses—undergo profound and specific changes as we age. These changes, far from ...
MAGIC: AI-assisted laser tag illuminates cancer origins
2025-10-29
The human body relies on precise genetic instructions to function, and cancer begins when these instructions get scrambled. When cells accumulate genetic errors over time, they can break free of the normal controls on their growth and divide excessively. Chromosomal abnormalities – numerical and structural defects in chromosomes – are a common first step in this process, often contributing to normal cells turning cancerous.
A new AI tool developed by researchers in the Korbel Group at EMBL Heidelberg now offers a powerful method to gain deep insights ...
Major milestone achieved in capturing ribosome assembly
2025-10-29
Ribosomes are the cell's protein factories, which read the genetic code and assemble the proteins that every organism needs to live. But as far as how ribosomes themselves were formed, tantalizingly little was known.
Now, scientists have captured a key part of this process, in motion. The findings, published in Nature, combine artificial intelligence, cryo-electron microscopy, and genetics to reveal, in unprecedented detail, how cells coordinate, regulate, and safeguard the creation of the small ribosomal subunit—a machine central to forming every protein.
"We finally have a molecular movie of ribosome formation—we've ...
International research team decodes the pangenome of oats
2025-10-29
The pangenome is central to our understanding of cultivated plants such as oats, as it maps their entire genetic diversity. It encompasses not only genes that occur in all plants, but also those that are only present in certain species, serving as a kind of map. In turn, the pantranscriptome shows which genes are active in different tissues, such as leaves, roots and seeds, and at different stages of development. It serves as a gene expression atlas. However, understanding how genetic differences influence individual plant traits is challenging, particularly in the case of oats. The oat genome ...
A doorstop for the brain’s electrical gates
2025-10-29
As information zings from cell to cell inside the brain, bursts of electricity spur its transmission. At Cold Spring Harbor Laboratory (CSHL), scientists have turned their attention to the tiny pores that let charged ions enter a cell—and the molecular gatekeepers that help control them.
CSHL structural biologist Hiro Furukawa studies NMDA receptors (NMDARs). These ion channels open in response to chemical signals from neurons or drugs. The channels must be carefully regulated. When they open too wide or stay shut ...
Tiny 3D printer reconstructs tissues during vocal cord surgery
2025-10-29
After vocal cord surgery, many patients develop stiff vocal folds that impact their ability to speak. Hydrogels can help prevent this by promoting healing, but delivering hydrogels to the vocal cords is difficult. Publishing October 29 in the Cell Press journal Device, a team of biomechanical engineers and surgeons have developed a 3D-printing soft robot that can accurately deliver hydrogels to the vocal cord surgical site to reconstruct tissues removed during surgery. The robot’s printhead is only 2.7 mm in size—the smallest bioprinter reported to date.
“Our device is designed not only for accuracy and printing ...
New genetic marker found to predict severe gout drug reactions in US patients
2025-10-29
A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.
While the gene HLA-B*58:01 has long been used to screen patients in Southeast Asia — where it accounts for nearly all cases of severe cutaneous adverse reactions (SCARs) — it misses more than one-third of patients at risk in the U.S. and up to 45% of Black individuals who would be at risk of severe reactions if prescribed.
Now, researchers at Vanderbilt University Medical Center have discovered ...